Your browser doesn't support javascript.
loading
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer.
Iyer, Prajish; Shrikhande, Shailesh V; Ranjan, Malika; Joshi, Asim; Gardi, Nilesh; Prasad, Ratnam; Dharavath, Bhasker; Thorat, Rahul; Salunkhe, Sameer; Sahoo, Bikram; Chandrani, Pratik; Kore, Hitesh; Mohanty, Bhabani; Chaudhari, Vikram; Choughule, Anuradha; Kawle, Dhananjay; Chaudhari, Pradip; Ingle, Arvind; Banavali, Shripad; Gera, Poonam; Ramadwar, Mukta R; Prabhash, Kumar; Barreto, Savio George; Dutt, Shilpee; Dutt, Amit.
Afiliação
  • Iyer P; Integrated Cancer Genomics Laboratory, Advanced Centre for Treatment Research Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Shrikhande SV; Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Ranjan M; Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Joshi A; Department of Gastrointestinal and Hepato-Pancreato-Biliary Surgical Oncology, Tata Memorial Centre, Ernest Borges Marg, Mumbai, Maharashtra, India.
  • Gardi N; Integrated Cancer Genomics Laboratory, Advanced Centre for Treatment Research Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Prasad R; Integrated Cancer Genomics Laboratory, Advanced Centre for Treatment Research Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Dharavath B; Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Thorat R; Integrated Cancer Genomics Laboratory, Advanced Centre for Treatment Research Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Salunkhe S; Integrated Cancer Genomics Laboratory, Advanced Centre for Treatment Research Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Sahoo B; Integrated Cancer Genomics Laboratory, Advanced Centre for Treatment Research Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Chandrani P; Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Kore H; Laboratory Animal Facility, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Mohanty B; Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Chaudhari V; Shilpee laboratory, Advanced Centre for Treatment Research Education In Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Choughule A; Integrated Cancer Genomics Laboratory, Advanced Centre for Treatment Research Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Kawle D; Integrated Cancer Genomics Laboratory, Advanced Centre for Treatment Research Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Chaudhari P; Integrated Cancer Genomics Laboratory, Advanced Centre for Treatment Research Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Ingle A; Small Animal Imaging facility, Advanced Centre for Treatment Research Education In Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Banavali S; Department of Gastrointestinal and Hepato-Pancreato-Biliary Surgical Oncology, Tata Memorial Centre, Ernest Borges Marg, Mumbai, Maharashtra, India.
  • Gera P; Department of Medical Oncology, Tata Memorial Centre, Ernest Borges Marg, Mumbai, Maharashtra, India.
  • Ramadwar MR; Integrated Cancer Genomics Laboratory, Advanced Centre for Treatment Research Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Prabhash K; Small Animal Imaging facility, Advanced Centre for Treatment Research Education In Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Barreto SG; Laboratory Animal Facility, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Dutt S; Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Dutt A; Department of Medical Oncology, Tata Memorial Centre, Ernest Borges Marg, Mumbai, Maharashtra, India.
Int J Cancer ; 144(8): 2008-2019, 2019 04 15.
Article em En | MEDLINE | ID: mdl-30304546
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Receptor ErbB-2 / Neoplasias da Vesícula Biliar / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Receptor ErbB-2 / Neoplasias da Vesícula Biliar / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2019 Tipo de documento: Article